icon-folder.gif   Conference Reports for NATAP  
 
  65th Annual Meeting of the
American Association for the
Study of Liver Diseases
Boston, MA Nov 7-11 2014
Back grey_arrow_rt.gif
 
 
 
Treatment with Interferon- and Ribavirin-Free Regimens with Ledipasvir and Sofosbuvir Improves Patient-Reported Outcomes for Patients with Genotype 1 Chronic Hepatitis C: Results from the ION-1, 2 and 3 Clinical Trials
 
 
  Reported by Jules Levin
AASLD 2014 Nov 7-11 Boston
 
Zobair M. Younossi1,2,7, Maria Stepanova2,7, Patrick Marcellin3, Nezam H. Afdhal4, Kris V. Kowdley5, Stefan Zeuzem6, Sharon L. Hunt7
1. Center for Liver Disease, Inova Fairfax Hospital, Falls Church, VA
2. Department of Medicine, Inova Fairfax Hospital, Falls Church, VA
3. Viral Hepatitis Research Unit , Hopital Beaujon, Clichy, France.
4. Hepatology, Beth Israel Deaconess Medical Center, Boston, MA, United States.
5. Digestive Diseases Institute, Virginia Mason Clinic, Seattle, WA, United States.
6. Department of Medicine, J.W. Goethe University Hospital, Frankfurt, Germany.
7. Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif

AASLD9.gif

AASLD10.gif

AASLD11.gif

AASLD12.gif

AASLD13.gif

AASLD14.gif

AASLD15.gif